Zobrazeno 1 - 10
of 33
pro vyhledávání: '"I. Villar-Fernández"'
Autor:
P. Carrera Lasfuentes, I. Villar-Fernández, M. Izuel-Rami, M.J. Rabanaque Hernández, J.M. Real Campaña, E. Soler-Giner
Publikováno v:
Farmacia Hospitalaria. 35:165-171
Introduction: The objective of the study was to assess home medication data collected at the Emergency Department in a tertiary hospital. It also aimed to identify whether any possible deficiencies in this collection were translated as reconciliation
Autor:
P. Carrera Lasfuentes, J.M. Real Campaña, E. Soler-Giner, M. Izuel-Rami, M.J. Rabanaque Hernández, I. Villar-Fernández
Publikováno v:
Farmacia Hospitalaria (English Edition). 35:165-171
Introduction The objective of the study was to assess home medication data collected at the emergency department in a tertiary hospital. It also aimed to identify whether any possible deficiencies in this collection were translated as reconciliation
Autor:
E, Soler-Giner, M, Izuel-Rami, I, Villar-Fernández, J M, Real Campaña, P, Carrera Lasfuentes, M J, Rabanaque Hernández
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 35(4)
The objective of the study was to assess home medication data collected at the Emergency Department in a tertiary hospital. It also aimed to identify whether any possible deficiencies in this collection were translated as reconciliation errors on adm
Publikováno v:
Villar-Fernández, I, Bjerrum, L, Feja, C & Rabanaque, M J 2009, ' Variability in the prescription of cholinesterase inhibitors and memantine ', Dementia and Geriatric Cognitive Disorders, vol. 28, no. 4, pp. 373-379 . https://doi.org/10.1159/000253845
Background/Aim: To estimate the prevalence of Alzheimer’s disease (AD) treatment in Aragon (Spain), analyzing differences according to age, gender and health area. Methods: Retrospective study on AD treatment prevalence of cholinesterase inhibitors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a99f5351383156b8b73b2ae03095bddf
https://portal.findresearcher.sdu.dk/da/publications/d2fba230-011d-11df-aefb-000ea68e967b
https://portal.findresearcher.sdu.dk/da/publications/d2fba230-011d-11df-aefb-000ea68e967b
Autor:
I, Villar Fernández, M J, Rabaneque Hernández, J, Armesto Gómez, E, García Arilla, M, Izuel Rami
Publikováno v:
Neurologia (Barcelona, Spain). 22(5)
To evaluate the consumption evolution and financial impact of specific treatments for Alzheimer's disease (AD) in Aragon (Spain), analyzing consumption patterns and trends, and to estimate the proportion of AD patients treated with these drugs.Descri
Autor:
I, Villar Fernández, E, Urbieta Sanz, M, Arenere Mendoza, G, López Larramona, F, Marcilla Córdoba, M J, Rabanaque Hernández
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 28(6)
Sufficient evidence exists to recommend routine thromboembolic disease prophylaxis for medical inpatients with risk factors --with low-molecular-weight-- heparins being (LMWH) the most suitable treatment option. The objective is to determine the thro
Autor:
M A, Allende Bandrés, M, Izuel Rami, E, Urbieta Sanz, I, Villar Fernández, J, Carcelén Andrés
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 28(1)
Antiepileptic hypersensitivity syndrome (SHA) is a rare (1/1.000 to 1/10.000 in new exposures) but potentially life-threatening syndrome that occurs after exposure to an anticonvulsant, most commonly the aromatic ones such as phenytoin, carbamazepine
Autor:
I Villar Fernández, E Urbieta Sanz, G López Larramona, F Marcilla Córdoba, M. Arenere Mendoza, M.J. Rabanaque Hernández
Publikováno v:
Farmacia Hospitalaria. 29:69-70
Introducci?n: Existe suficiente evidencia para recomendar la tromboprofilaxis rutinaria en pacientes m?dicos con factores de riesgo, siendo las heparinas de bajo peso molecular (HBPM) la opci?n m?s adecuada para realizarla. El objetivo es conocer el
Autor:
I. Villar Fernández, E. Urbieta Sanz
Publikováno v:
Farmacia Hospitalaria. 29:70-71
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.